Prevention of liver cancer cachexia-induced cardiac wasting and heart failure

Jochen Springer, Anika Tschirner, Arash Haghikia, Stephan von Haehling, Hind Lal, Aleksandra Grzesiak, Elena Kaschina, Sandra Palus, Mareike Pötsch, Karoline von Websky, Berthold Hocher, Celine Latouche, Frederic Jaisser, Lars Morawietz, Andrew J S Coats, John Beadle, Josep M Argiles, Thomas Thum, Gabor Földes, Wolfram DoehnerDenise Hilfiker-Kleiner, Thomas Force, Stefan D Anker

Research output: Contribution to journalArticlepeer-review

112 Citations (Scopus)

Abstract

Symptoms of cancer cachexia (CC) include fatigue, shortness of breath, and impaired exercise capacity, which are also hallmark symptoms of heart failure (HF). Herein, we evaluate the effects of drugs commonly used to treat HF (bisoprolol, imidapril, spironolactone) on development of cardiac wasting, HF, and death in the rat hepatoma CC model (AH-130).
Original languageEnglish
Pages (from-to)932-941
JournalEuropean Heart Journal
Volume35
Issue number14
Early online date29 Aug 2013
DOIs
Publication statusPublished - 2014

Cite this